# Effectiveness of Early Intervention in Transfusion Independent Aplastic Anemia: a Retrospective Medical Claims Database Study

> **NCT06669221** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 1603 (actual)

## Conditions studied

- Aplastic Anemia (AA)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06669221
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-05
- **Primary completion:** 2023-11-03
- **Final completion:** 2023-11-03
- **Target enrollment:** 1603 (ACTUAL)
- **Last updated:** 2024-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06669221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06669221, "Effectiveness of Early Intervention in Transfusion Independent Aplastic Anemia: a Retrospective Medical Claims Database Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06669221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*